Category Archives: Uncategorized

New Bankruptcy Court Case Filed in the Bankruptcy Court: 2:17-ap-01174-NB Stardust Vacation Club and Americana Vacation Club v. MacMillan





A new case was just opened in the Bankruptcy Court. The case number and the debtor’s name/adversary complaint plaintiff(s) and defendant(s) are: 2:17-ap-01174-NB Stardust Vacation Club and Americana Vacation Club v. MacMillan.

New Bankruptcy Court Case Filed in the Bankruptcy Court: 1-17-01021-cec Midwood Gardens LLC v. Fishoff





A new case was just opened in the Bankruptcy Court. The case number and the debtor’s name/adversary complaint plaintiff(s) and defendant(s) are: 1-17-01021-cec Midwood Gardens LLC v. Fishoff.

This is a breaking news story. More details about this bankruptcy court filing are available on Chapter11Dockets.com.

New Current Report Filed with the SEC Disclosing Receipt of a Notice of Delisting, the Failure to Satisfy a Continued Listing Rule or Standard or the Transfer of a Listing: 8-K – CYTRX CORP (0000799698) (Filer)

A current report on Form 8-K was just filed with the U.S. Securities & Exchange Commission (SEC) disclosing receipt of a notice of delisting, the failure to satisfy a continued listing rule or standard or the transfer of a listing. Details of the current report are:

8-K – CYTRX CORP (0000799698) (Filer)
Filed: 2017-02-24 AccNo: 0000799698-17-000003 Size: 24 KB

Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Filing Date: 2017-02-24T17:13:27-05:00

This is a breaking news story. You can access the complete current report through the SEC’s Edgar system: http://www.sec.gov/Archives/edgar/data/799698/000079969817000003/0000799698-17-000003-index.htm

New Current Report Filed with the SEC Disclosing Receipt of a Notice of Delisting, the Failure to Satisfy a Continued Listing Rule or Standard or the Transfer of a Listing: 8-K – Biostar Pharmaceuticals, Inc. (0001418133) (Filer)

A current report on Form 8-K was just filed with the U.S. Securities & Exchange Commission (SEC) disclosing receipt of a notice of delisting, the failure to satisfy a continued listing rule or standard or the transfer of a listing. Details of the current report are:

8-K – Biostar Pharmaceuticals, Inc. (0001418133) (Filer)
Filed: 2017-02-24 AccNo: 0001185185-17-000447 Size: 21 KB

Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Filing Date: 2017-02-24T16:30:41-05:00

This is a breaking news story. You can access the complete current report through the SEC’s Edgar system: http://www.sec.gov/Archives/edgar/data/1418133/000118518517000447/0001185185-17-000447-index.htm

New Current Report Filed with the SEC Relating to Statement that Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review Should Not Be Relied Upon: 8-K – DASAN ZHONE SOLUTIONS INC (0001101680) (Filer)

A current report on Form 8-K was just filed with the U.S. Securities & Exchange Commission (SEC) relating to a statement that certain of the company’s previously-issued financial statements or a related audit report or completed interim review should not be relied upon by investors or other interested parties. Details of the current report are:

8-K – DASAN ZHONE SOLUTIONS INC (0001101680) (Filer)
Filed: 2017-02-24 AccNo: 0001101680-17-000008 Size: 38 KB

Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
Filing Date: 2017-02-24T16:20:28-05:00

This is a breaking news story. You can access the complete current report through the SEC’s Edgar system: http://www.sec.gov/Archives/edgar/data/1101680/000110168017000008/0001101680-17-000008-index.htm